Vulnerabilities

Vulnerability · CVE-2026-45296

OpenReplay is a self-hosted session replay suite.

Published May 28, 2026 · catalog updated Jun 17, 2026 · OpenReplay is a self-hosted

Check if you run it

No confirmed exploitation is on record for CVE-2026-45296. EPSS is 0.37%. Act only if a listed version of OpenReplay is a self-hosted is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (OpenReplay is a self-hosted).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.7
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.37%
Remediation
Advisory link
Affected products
See sources for product scope

OpenReplay is a self-hosted session replay suite. Prior to 1.26.0, OpenReplay's Python API exposes several app_apikey routes that trust a caller-provided projectKey after validating only that the API key itself is valid and that the target projectKey exists. The authorization flow does not verify that the authenticated API key and the requested project belong to the same tenant. Because the public tracker design exposes projectKey to browser-side code, an attacker who owns any valid API key for their own tenant can target another tenant's project by reusing that public projectKey. The vulnerable routes allow the attacker to enumerate victim user sessions and then retrieve sensitive session event data across the tenant boundary. This vulnerability is fixed in 1.26.0.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-45296

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-45296. EPSS is 0.37%. Act only if a listed version of OpenReplay is a self-hosted is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-284: Improper Access Control. EPSS 0.37%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. May 28, 2026 · NIST NVD

    Detected

    OpenReplay is a self-hosted session replay suite. Prior to 1.26.0, OpenReplay's Python API exposes several app_apikey routes that trust a caller-provided projectKey after validating only that the API key itself is valid and that the target projectKey exists. The authorization flow does not verify that the authenticated API key and the requested project belong to the same tenant. Because the public

  2. Jun 17, 2026 · NIST NVD

    Updated

    OpenReplay is a self-hosted session replay suite. Prior to 1.26.0, OpenReplay's Python API exposes several app_apikey routes that trust a caller-provided projectKey after validating only that the API key itself is valid and that the target projectKey exists. The authorization flow does not verify that the authenticated API key and the requested project belong to the same tenant. Because the public

Sources

  • CVE.orgVulnerability recordCVE-2026-45296

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-45296

    30-day exploitation probability 0.4%

    first.org
  • NIST NVDVulnerability recordCVE-2026-45296

    OpenReplay is a self-hosted session replay suite. Prior to 1.26.0, OpenReplay's Python API exposes several app_apikey routes that trust a caller-provided projectKey after validating only that the API key itself is valid and that the target projectKey exists. The authorization flo

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.